Huovinen P, Renkonen O V, Pulkkinen L, Sunila R, Grönroos P, Klossner M L, Virtanen S, Toivanen P
J Antimicrob Chemother. 1985 Oct;16(4):435-41. doi: 10.1093/jac/16.4.435.
Development of trimethoprim resistance among Escherichia coli collected from urine samples in three areas in Finland was studied in 1978-1984. Three different trends of development of resistance were found: in the Turku area resistance has increased evenly during 1978-1982 from 5.4% to 10.1%, but thereafter a plateau seems to have been reached; in the Helsinki area resistance increased rapidly from 2.9% in 1980 to 11.1% in 1984, possibly due to the spread of a trimethoprim resistance transposon Tn7, which occurred significantly more often among E. coli strains in this area than in the Turku area; in the Rovaniemi area resistance has been at a plateau level, between 3.1 and 5.7%, during the whole study. No clear correlation between the consumption of trimethoprim and the level of resistance was found. The frequency of trimethoprim resistance in E. coli isolated from patients less than 65 years was 5.2% and in those isolated from patients greater than or equal to 65 years 14.7%.
1978年至1984年期间,对芬兰三个地区尿液样本中分离出的大肠杆菌对甲氧苄啶耐药性的发展情况进行了研究。发现了三种不同的耐药性发展趋势:在图尔库地区,1978年至1982年期间耐药性从5.4%均匀上升至10.1%,但此后似乎达到了一个平台期;在赫尔辛基地区,耐药性从1980年的2.9%迅速上升至1984年的11.1%,这可能是由于甲氧苄啶耐药转座子Tn7的传播,该转座子在该地区大肠杆菌菌株中出现的频率明显高于图尔库地区;在罗瓦涅米地区,在整个研究期间耐药性一直处于3.1%至5.7%的平台期。未发现甲氧苄啶的使用量与耐药水平之间存在明显相关性。从65岁以下患者分离出的大肠杆菌中,甲氧苄啶耐药频率为5.2%,从65岁及以上患者分离出的大肠杆菌中,耐药频率为14.7%。